Finance

Lists
1099:HKG
Sinopharm Group Co Ltd
HK$ १५.७२
+०.४५%
(+०.०७०) 1D
अक्टोबर १६, १६:०८:१४ GMT+८  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1099...
Open
HK$ १५.७९
High
HK$ १५.९९
Low
HK$ १५.६७
Mkt. cap
४९.०६ अरब
Avg. vol.
४८.५४ लाख
Volume
५८.९० लाख
Dividend
५.०३%
Quarterly dividend
HK$ ०.२०
Ex-dividend date
२०२६ जुन २३
P/E ratio
५.९०
52-wk high
HK$ २२.३४
52-wk low
HK$ १४.५५
EPS
HK$ २.६७
Shares outstanding
१.१९ अरब
No. of employees
९० हजार
Open
HK$ १५.७९
High
HK$ १५.९९
Low
HK$ १५.६७
Mkt. cap
४९.०६ अरब
Avg. vol.
४८.५४ लाख
Volume
५८.९० लाख
Dividend
५.०३%
Quarterly dividend
HK$ ०.२०
Ex-dividend date
२०२६ जुन २३
P/E ratio
५.९०
52-wk high
HK$ २२.३४
52-wk low
HK$ १४.५५
EPS
HK$ २.६७
Shares outstanding
१.१९ अरब
No. of employees
९० हजार
News stories
From web sources and news partners
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm Group Co Ltd
CEO-
Employees९०.४ हजार
Founded२००३
Headquarters-
Sector-
Last report
२०२६ अगस्ट २४
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
१.४२ खरब / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.४५ खरब
१.४४ खरब
१.४१ खरब
१.४२ खरब
Cost of goods sold
१.३५ खरब
१.३३ खरब
१.३१ खरब
१.३२ खरब
Cost of revenue
१.३५ खरब
१.३३ खरब
१.३१ खरब
१.३२ खरब
Research and development expenses
१७.२६ करोड
-१७.२६ करोड
४.६६ करोड
-४.६६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५.१७ अरब
७.३४ अरब
५.१० अरब
५.७० अरब
Operating expense
६.८० अरब
५.०० अरब
६.२९ अरब
५.४५ अरब
Total operating expenses
१.४१ खरब
१.३८ खरब
१.३८ खरब
१.३८ खरब
Operating income
४.१२ अरब
५.४० अरब
३.०७ अरब
४.२६ अरब
Other non operating income
१२.०८ करोड
-४२.७४ करोड
३.९६ करोड
-१०.०८ करोड
EBT including unusual items
३.६७ अरब
३.९२ अरब
२.९० अरब
४.०५ अरब
EBT excluding unusual items
३.५१ अरब
५.३६ अरब
२.९० अरब
४.२५ अरब
Income tax expense
९०.५४ करोड
१.१९ अरब
७१.२३ करोड
१.०५ अरब
Effective tax rate
२४.६६%
३०.३०%
२४.५७%
२६.०२%
Other operating expenses
९१.७१ करोड
-१.१० अरब
२०.४५ करोड
-३९.२७ करोड
Net income
१.८४ अरब
१.८५ अरब
१.४१ अरब
१.९९ अरब
Net profit margin
१.२७%
१.२९%
१.००%
१.४०%
Earnings per share
-
-
-
-
Interest and investment income
३६.४२ करोड
-
१७.१३ करोड
-
Interest expense
-४१.२६ करोड
-८४.६६ करोड
-३८.३८ करोड
-५०.५८ करोड
Net interest expenses
-४.८३ करोड
-८४.६६ करोड
-२१.२६ करोड
-५०.५८ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
४.६६ अरब
५.९१ अरब
३.५८ अरब
४.७८ अरब
Gain or loss from assets sale
१.१८ करोड
-२.०५ करोड
-
-१.४३ करोड
AI content may include mistakes. Learn more
Google एपहरू